½ÃÀ庸°í¼­
»óǰÄÚµå
1402722

ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå ¿¹Ãø(-2030³â) - Áö¿ªº° ºÐ¼® : Á¦Ç°º°, ¿ëµµº°, Àç·áº°

North America Clinic Casting and Splinting Products Market Forecast to 2030 - Regional Analysis - by Product, Application (Acute Fractures or Sprains, Tendon and Ligament Injuries, and Others), and Material (Plaster of Paris, Fiberglass, and Others)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 87 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº 2022³â 5¾ï 6,748¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2030³â¿¡´Â 8¾ï 6,947¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2022³âºÎÅÍ 2030³â±îÁö CAGRÀº 5.5%·Î Àü¸ÁµË´Ï´Ù.

±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü »ó½ÂÀÌ ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀ» Ȱ¼ºÈ­

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, ±Ù°ñ°Ý°è ÁúȯÀº Àü ¼¼°èÀûÀ¸·Î Àå¾ÖÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖÀ¸¸ç, ¿äÅëÀº 160°³±¹¿¡¼­ Àå¾ÖÀÇ ´ÜÀÏ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±Ù°ñ°Ý°è ÁúȯÀº 2019³â Àå¾Ö¿Í ÇÔ²² »ì¾Ò´ø ¿¬¼ö(YLDs)¿¡¼­ ¼¼°è 1À§, Àå¾ÖÁ¶Á¤ »ýÁ¸³â(DALYs)¿¡¼­ ¼¼°è 6À§°¡ µÆ½À´Ï´Ù. WHO¿¡ µû¸£¸é 2021³â¿¡´Â Àü ¼¼°è 17¾ï 1,000¸¸ ¸íÀÌ ±Ù°ñ°Ý°è ÁúȯÀ» ¾Î¾Ò½À´Ï´Ù. National Library of Medicine¿¡ °ÔÀçµÈ ¡°Global prevalence of musculoskeletal disorders among physiotherapists: a systematic review and meta-analysis¡±¶ó´Â Á¦¸ñÀÇ ¿¬±¸¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â ±Ù°ñ°Ý°è ÁúȯÀÇ ÀÌȯÀ²ÀÌ Áõ°¡ÇÏ¿´½À´Ï´Ù.

·ù¸¶Æ¼½º °üÀý¿°(RA), °ñ°üÀý¿°(OA), ¿äÅë(LBP), °æºÎÅë(NP) µîÀº ÀϹÝÀûÀÎ ±Ù°ñ°Ý°è ÁúȯÀÔ´Ï´Ù. 2023³â ½ºÇÁ¸°Àú ³×ÀÌó(Springer Nature)°¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é ÁÖ¿ä ÀÚ°¡¸é¿ª¼º ·ù¸¶Æ¼½º Áúȯ Áß ÇϳªÀÎ ·ù¸¶Æ¼½º °üÀý¿°Àº ¼¼°è 1,400¸¸ ¸íÀÌ ¾Î¾Ò½À´Ï´Ù. °üÀýÅëÀº Àü¹®ÀǸ¦ ¼Ò°³ÇÏ´Â °¡Àå ÀϹÝÀûÀÎ ÀÌÀ¯ÀÔ´Ï´Ù. ¼®°í ¹× ºÎ¸ñ´Â ´Ù¾çÇÑ ±Ù°ñ°Ý°è ÁúȯÀÇ °ü¸®¿¡ »ç¿ëµË´Ï´Ù. ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϸ鼭 È¿°ú¸¦ ±Ø´ëÈ­Çϱâ À§ÇØ ¼®°í ¹× ºÎ¸ñÀÇ »ç¿ëÀº ÀϹÝÀûÀ¸·Î ´Ü±â°£À¸·Î Á¦Çѵ˴ϴÙ. µû¶ó¼­, ±Ù°ñ°Ý°è ÁúȯÀÇ ÀÌȯÀ²ÀÇ »ó½ÂÀÌ ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì Ŭ¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå °³¿ä

ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ¼¼ºÐÈ­µÇ¾î ÀÖÀ¸¸ç ÀÌ Áö¿ª ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº °ñ´Ù°øÁõÀ̳ª ±Ù°ñ°Ý°èÀÇ ¼Õ»ó·üÀÇ »ó½Â, ³ëÀÎ Àα¸ Áõ°¡¿¡ ÀÇÇÑ ¿¬·É °ü·Ã Á¤Çü¿Ü°ú Áúȯ Áõ°¡¿¡ ÀÇÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÁßÇÏ°Ô °í·ÁÇÑ »óȯ ±ÔÁ¦´Â ºñ½Ñ ¼®°í ¹× ºÎ¸ñ Á¦Ç°¿¡ ´ëÇÑ ¾×¼¼½º¸¦ °¡´ÉÇÏ°Ô ÇÏ°í ½ÃÀå ¼ºÀåÀ» Áö¿øÇÕ´Ï´Ù.

United States Bone and Joint Initiative(USBJI)¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ±Ù°ñ°Ý°è ÁúȯÀÌ 65¼¼ ÀÌ»ó °ÅÀÇ 4¸í Áß 3¸í, 18¼¼ ÀÌ»ó 2¸í Áß 1¸í¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù°í ÇÕ´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æ°ü¸®¼¾ÅÍ(CDC)¿¡ µû¸£¸é 2019³â¿¡´Â ¹Ì±¹ ¼ºÀÎ Áß 5,410¸¸ ¸íÀÌ 65¼¼ ÀÌ»óÀ¸·Î Àα¸ÀÇ 16%¸¦ Â÷ÁöÇß½À´Ï´Ù. 2040³â¿¡´Â ³ëÀÎ ¼ö°¡ 8,080¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2060³â¿¡´Â 9,470¸¸ ¸í¿¡ ´ÞÇÒ Àü¸ÁÀ̸ç, ³ëÀεéÀº ¹Ì±¹ Àα¸ÀÇ 25% °¡±îÀ̸¦ Â÷ÁöÇÏ°Ô µË´Ï´Ù. Á¤Çü¿Ü°úÀû ¼Õ»óÀº ³ëÀÎ ½ÅüÀÇ »ý¹°ÇÐÀû º¯È­·Î ÀÎÇØ ³ëÀÎ Àα¸¿¡¼­ ÈçÈ÷ º¼ ¼ö ÀÖ½À´Ï´Ù. ³ªÀ̰¡ µé¼ö·Ï °ñ¹Ðµµ°¡ ¶³¾îÁý´Ï´Ù. ±Ù°ñ°Ý°è ÁúȯÀº ¹Ì±¹ Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó ÇØ¸¶´Ù Å« ºÎ´ãÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³ëÀÎÀÌ Á÷¸éÇÏ´Â ½É°¢ÇÑ ¹®Á¦ Áß Çϳª´Â °ñÀýÀÔ´Ï´Ù. ¶ÇÇÑ °ñ¹Ðµµ¿Í °ñÁú ÀúÇϸ¦ ÀÏÀ¸Å°´Â ´ë»ç¼º °ñÁúȯÀÎ °ñ´Ù°øÁõÀº ¹Ì±¹¿¡¼­´Â °Ç°­¸é¿¡¼­³ª °æÁ¦¸é¿¡¼­µµ Å« ºÎ´ãÀÌ µÇ°í ÀÖ½À´Ï´Ù. °ñÀýÀº ¾î¶² »À¿¡¼­µµ ¹ß»ýÇÒ ¼ö ÀÖÁö¸¸, °í°üÀý°ú ôÃßÀÇ °ñÀýÀÌ °¡Àå ¸¹¾Æ °ñ´Ù°øÁõ °ñÀý ÀüüÀÇ 42%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¹Ì±¹¿¡¼­´Â ¿¬°£ 70¸¸ °Ç ÀÌ»óÀÇ Ã´Ãß ¾Ð¹Ú °ñÀýÀÌ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â 50¼¼ ÀÌ»óÀÇ ¿©¼º Áß 2¸í Áß 1¸íÀÌ Æò»ý µ¿¾È °ñ´Ù°øÁõ°ú °ü·ÃµÈ °ñÀýÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù.

´Ù¾çÇÑ ±Ù°ñ°Ý°è ÁúȯÀÇ °ü¸®¿¡´Â ¼®°í ¹× ºÎ¸ñÀÇ »ç¿ëÀÌ ÇÊ¿äÇÕ´Ï´Ù. ºÎ¸ñÀº º×±â¿¡ ÇØ´çÇÏ´Â ºñÁÖÀ§ °íÁ¤±¸ÀÔ´Ï´Ù. ÀÌ Æ¯¼ºÀ¸·Î ÀÎÇØ, ºÎ¸ñÀº ±Þ¼º °ñÀý, ¿°Á ¶Ç´Â Á¤Çü¿Ü°úÀû °³ÀÔ ÀüÀÇ Ãà¼Ò °ñÀý, ÀüÀ§ °ñÀý ¹× ºÒ¾ÈÁ¤ °ñÀýÀÇ Ãʱ⠾ÈÁ¤È­¿Í °°Àº ºÎÁ¾ÀÌ ¿¹»óµÇ´Â ´Ù¾çÇÑ ±Þ¼º ±Ù°ñ°Ý°è »óŸ¦ °ü¸®ÇÏ´Â µ¥¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. µû¶ó¼­ ±Ù°ñ°Ý°è Áúȯ°ú °ñ´Ù°øÁõÀÇ À¯º´·ü »ó½ÂÀº ¹Ì±¹¿¡¼­ ¼®°í ¹× ºÎ¸ñ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå ¼öÀÍ ¹× ¿¹Ãø(±Ý¾×)(-2030³â)

ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå ¼¼ºÐÈ­

ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº Á¦Ç°, ¿ëµµ, Àç·á, ±¹°¡·Î ±¸ºÐµË´Ï´Ù.

Á¦Ç°º°·Î ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº ¼®°í¿Í ºÎ¸ñÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â ºÏ¹Ì Ŭ¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå¿¡¼­´Â ¼®°í ºÎ¹®ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¼®°í´Â ¼®°í, Å×ÀÌÇÁ, Ä¿ÅÍ, ¼®°í¿ë ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ºÎ¸ñ ºÐ¾ß´Â ºÎ¸ñ°ú ºÎ¸ñ¿ë ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù.

¿ëµµº°·Î ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº ±Þ¼º °ñÀý ¶Ç´Â ¿°ÁÂ, ÈûÁÙ ¹× ÀÎ´ë ¼Õ»ó µîÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â¿¡´Â ±Þ¼º °ñÀý ºÎ¹®ÀÌ ºÏ¹Ì Ŭ¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Àç·áº°·Î ºÏ¹Ì Ŭ¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº ÆÄ¸® ¼®°í, À¯¸® ¼¶À¯ µîÀ¸·Î ±¸ºÐµË´Ï´Ù. ÆÄ¸® ¼®°í ºÎ¹®Àº 2022³â ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. 2022³â ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀåÀº ¹Ì±¹ÀÌ Áö¹èÀûÀ̾ú½À´Ï´Ù.

3M Co, Corflex Inc, DeRoyal Industries Inc, Dynatronics Corporation, Enovis Corp, Essity AB, Ossur hf, Performance Health Holding Inc, Zimmer Biomet Holdings Inc.´Â ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå »óȲ

  • °³°ü
  • PEST ºÐ¼®
    • ºÏ¹ÌÀÇ PEST ºÐ¼®
  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀÎÀÇ º¥´õ À϶÷

Á¦5Àå ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ÁÖ¿ä »ê¾÷¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü »ó½Â
    • ³ëÈ­¿¡ µû¸¥ Á¤Çü¿Ü°ú ÁúȯÀÇ ³ôÀº À¯º´·ü
  • ÁÖ¿ä ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼®°í °íÁ¤ ¹× ºÎ¸ñ¿¡ °üÇÑ ÇÕº´Áõ
  • ÁÖ¿ä ½ÃÀå ±âȸ
    • ¼®°í ºØ´ë ¹× ºÎ¸ñ¿¡¼­ 3D ±â¼úÀÇ ¹ßÀü
  • ÇâÈÄÀÇ µ¿Çâ
    • ¼®°í ºØ´ë ¹× ºÎ¸ñ¿¡ À־ ¼¶À¯ À¯¸® Àç·áÀÇ Ã¤¿ë Áõ°¡
  • ¿µÇ⠺м®

Á¦6Àå Ŭ¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®

  • ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå ¼öÀÍ(2022-2030³â)

Á¦7Àå ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ¼öÀͰú ¿¹Ãø(-2030³â) : Á¦Ç°º°

  • ¼­·Ð
  • ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : Á¦Ç°º° ¸ÅÃâ Á¡À¯À²(%)(2022³â ¹× 2030³â)
  • ¼®°í ºØ´ë
  • ºÎ¸ñ

Á¦8Àå ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ¼öÀͰú ¿¹Ãø(-2030³â) : ¿ëµµº°

  • ¼­·Ð
  • ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ¿ëµµº° ¸ÅÃâ¾× Á¡À¯À²(%)(2022³â ¹× 2030³â)
  • ±Þ¼º °ñÀý ¶Ç´Â ¿°ÁÂ
  • ÈûÁÙ ¹× ÀÎ´ë ¼Õ»ó
  • ±âŸ

Á¦9Àå ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ¼öÀͰú ¿¹Ãø(-2030³â) : Àç·áº°

  • ¼­·Ð
  • ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : Àç·áº° ¸ÅÃâ Á¡À¯À²(%)(2022³â ¹× 2030³â)
  • ÆÄ¸® ¼®°í
  • À¯¸® ¼¶À¯
  • ±âŸ

Á¦10Àå ºÏ¹Ì Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå : ¼öÀͰú ¿¹Ãø(-2030³â): ±¹°¡º° ºÐ¼®

Á¦11Àå ºÏ¹ÌÀÇ Å¬¸®´Ð¿ë ¼®°í ¹× ºÎ¸ñ Á¦Ç° ½ÃÀå-¾÷°è Á¤¼¼

  • ¼­·Ð
  • ÃÖ±Ù ¼ºÀå Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • DeRoyal Industries Inc
  • 3M Co
  • Corflex Inc
  • Essity AB
  • Dynatronics Corporation
  • Zimmer Biomet Holdings Inc
  • Ossur hf
  • Performance Health Holding Inc
  • Enovis Corp

Á¦13Àå ºÎ·Ï

AJY 24.01.18

The North America clinic casting and splinting products market is expected to grow from US$ 567.48 million in 2022 to US$ 869.47 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Rising Prevalence of Musculoskeletal Conditions Fuels North America Clinic Casting and Splinting Products Market

According to the World Health Organization (WHO) musculoskeletal conditions are the leading cause of disability across the world, and low back pain is the single leading cause of disability in 160 countries. Musculoskeletal disorders ranked first in years lived with disability (YLDs) and sixth in disability-adjusted life-years (DALYs) globally in 2019. According to WHO, ~1.71 billion people across the world had musculoskeletal conditions in 2021. According to a study titled "Global prevalence of musculoskeletal disorders among physiotherapists: a systematic review and meta-analysis" published in the National Library of Medicine, there has been an increase in the incidence of musculoskeletal diseases in the US.

Rheumatoid arthritis (RA), osteoarthritis (OA), low-back pain (LBP), and neck pain (NP) are a few common musculoskeletal conditions. According to an article published by Springer Nature in 2023, rheumatoid arthritis, one of the main autoimmune rheumatic diseases, affects 14 million people worldwide. Joint pain is the most common reason for specialist referrals. Cast or splint is used in the management of various musculoskeletal conditions. To maximize benefits while minimizing complications, the use of casts and splints is generally limited to the short term. Thus, the rising incidence of musculoskeletal conditions is driving the growth of the North America clinic casting and splinting products market .

North America Clinic Casting and Splinting Products Market Overview

The North America clinic casting and splinting products market has been segmented into the US, Canada, and Mexico; being the major contributors to the market growth in this region. The North America casting and splinting market is growing because of the rising rates of osteoporosis and musculoskeletal injuries and increased rates of age-related orthopedic disorders brought on by the growing geriatric population. Furthermore, carefully thought-out reimbursement regulations enable access to pricey casting and splinting equipment, supporting market growth.

According to the United States Bone and Joint Initiative (USBJI), musculoskeletal diseases affect nearly three out of four people aged 65 and over and one in every two persons aged 18 and above in the US. According to Centers for Disease Control and Prevention (CDC), in 2019, 54.1 million US adults were 65 or older, representing 16% of the population. By 2040, the number of older adults is expected to reach 80.8 million. By 2060, it will reach 94.7 million, and older adults will make up nearly 25% of the US population. Orthopedic injuries are common in the aging population due to biological changes in older adults' bodies. As people grow older, their bone mineral density decreases. Musculoskeletal diseases are becoming a greater burden every year with the aging US population. One of the serious problems facing the elderly is fractures. Moreover, osteoporosis, a metabolic bone disease that causes reduced mineral density and quality of bone, is a significant health and economic burden in the US. Fractures can occur in any bone; however, hip and spine fractures are the most common, accounting for 42% of all osteoporotic fractures. More than 700,000 vertebral body compression fractures occur per year in the United States. In the US, one in two women over 50 have an osteoporosis-related bone break in their lifetime.

The management of a wide variety of musculoskeletal conditions requires the use of a cast or splint. Splints are noncircumferential immobilizers that accommodate swelling. This quality makes splints ideal for the management of a variety of acute musculoskeletal conditions in which swelling is anticipated, such as acute fractures or sprains or initial stabilization of reduced, displaced, or unstable fractures before orthopedic intervention. Thus, the rising prevalence of musculoskeletal conditions and osteoporosis will boost the demand for casting and splinting products in the US.

North America Clinic Casting and Splinting Products Market Revenue and Forecast to 2030 (US$ Million)

North America Clinic Casting and Splinting Products Market Segmentation

The North America clinic casting and splinting products market is segmented into product, application, material, and country.

Based on product, the North America clinic casting and splinting products market is segmented into casting and splinting. The casting segment held a larger share of the North America clinic casting and splinting products market in 2022. The casting is sub-segmented into casts, tapes, cutters, and casting accessories. The splinting segment is further segmented into splints and splinting accessories.

Based on application, the North America clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures segment held the largest share of the North America clinic casting and splinting products market in 2022.

Based on material, the North America clinic casting and splinting products market is segmented into Plaster of Paris, fiberglass, and others. The Plaster of Paris segment held the largest share of the North America clinic casting and splinting products market in 2022.

Based on country, the North America clinic casting and splinting products market is segmented into the US, Canada, and Mexico. The US dominated the North America clinic casting and splinting products market in 2022.

3M Co, Corflex Inc, DeRoyal Industries Inc, Dynatronics Corporation, Enovis Corp, Essity AB, Ossur hf, Performance Health Holding Inc, and Zimmer Biomet Holdings Inc are some of the leading companies operating in the North America clinic casting and splinting products market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Clinic Casting and Splinting Products Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Clinic Casting and Splinting Products Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Clinic Casting and Splinting Products Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. North America Clinic Casting and Splinting Products Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Musculoskeletal Conditions
    • 5.1.2 High Prevalence of Age-Related Orthopedic Disorders
  • 5.2 Key Market Restraints
    • 5.2.1 Complications Related to Casting and Splinting
  • 5.3 Key Market Opportunities
    • 5.3.1 Advancements in 3D Technology in Casting and Splinting
  • 5.4 Future Trends
    • 5.4.1 Rising Adoption of Fiberglass Material for Casting and Splinting
  • 5.5 Impact Analysis

6. Clinic Casting and Splinting Products Market - North America Market Analysis

  • 6.1 North America Clinic Casting and Splinting Products Market Revenue (US$ Mn), 2022 - 2030

7. North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America Clinic Casting and Splinting Products Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Casting
    • 7.3.1 Overview
    • 7.3.2 Casting: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Casts
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Casts: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.2 Tapes
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Tapes: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.3 Cutters
        • 7.3.2.3.1 Overview
        • 7.3.2.3.2 Cutters: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.4 Casting Accessories
        • 7.3.2.4.1 Overview
        • 7.3.2.4.2 Casting Accessories: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Splinting
    • 7.4.1 Overview
    • 7.4.2 Splinting: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 Splints
        • 7.4.2.1.1 Overview
        • 7.4.2.1.2 Splints: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.2 Splinting Accessories
        • 7.4.2.2.1 Overview
        • 7.4.2.2.2 Splinting Accessories: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Clinic Casting and Splinting Products Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Acute Fracture or Sprains
    • 8.3.1 Overview
    • 8.3.2 Acute Fracture or Sprains: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Tendon and Ligament Injuries
    • 8.4.1 Overview
    • 8.4.2 Tendon and Ligament Injuries: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 - by Material

  • 9.1 Overview
  • 9.2 North America Clinic Casting and Splinting Products Market Revenue Share, by Material 2022 & 2030 (%)
  • 9.3 Plaster of Paris
    • 9.3.1 Overview
    • 9.3.2 Plaster of Paris: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Fiberglass
    • 9.4.1 Overview
    • 9.4.2 Fiberglass: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 North America Clinic Casting and Splinting Products Market
    • 10.1.1 Overview
      • 10.1.1.1 US: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 US: North America Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.3.1 US: North America Clinic Casting and Splinting Products Market, For Casting by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.3.2 US: North America Clinic Casting and Splinting Products Market, For Splinting by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: North America Clinic Casting and Splinting Products Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.5 US: North America Clinic Casting and Splinting Products Market, by Material, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: North America Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.3.1 Canada: North America Clinic Casting and Splinting Products Market, For Casting by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.3.2 Canada: North America Clinic Casting and Splinting Products Market, For Splinting by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: North America Clinic Casting and Splinting Products Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Canada: North America Clinic Casting and Splinting Products Market, by Material, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: North America Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: North America Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.3.1 Mexico: North America Clinic Casting and Splinting Products Market, For Casting by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.3.2 Mexico: North America Clinic Casting and Splinting Products Market, For Splinting by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: North America Clinic Casting and Splinting Products Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Mexico: North America Clinic Casting and Splinting Products Market, by Material, 2020-2030 (US$ Million)

11. North America Clinic Casting and Splinting Products Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Recent Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 DeRoyal Industries Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 3M Co
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Corflex Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Essity AB
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Dynatronics Corporation
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Zimmer Biomet Holdings Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Ossur hf
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Performance Health Holding Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Enovis Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦